EUVIMEDEUVIMED entdecken
Crossref

Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment

Lina Hao iD, Xiufen Qu iD

British Journal of Pharmacology · 2026-12 · 183 (23) · 6903-6926

DOI: 10.1111/bph.70633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 24.08.2026. Verfasst von Lina Hao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Wnt Signaling Pathway, Tretinoin. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Diabetic cardiomyopathy (DCM) lacks effective therapies because of complex mechanisms. This study aims to develop a single‐atom nanozyme for integrated antioxidant and signalling regulation in DCM. Experimental Approach A graphene quantum dot‐templated single‐atom Pt‐N‐C nanozyme (PtsaN‐C) was synthesised for all‐trans retinoic acid (ATRA) delivery (PtsaN‐C@ATRA). In vitro antioxidant activity and in vivo efficacy were evaluated in DCM mice, combined with scRNA‐seq for mechanistic analysis. Key Results PtsaN‐C@ATRA improved cardiac function, reduced fibrosis/apoptosis and activated the Rara/Wnt/β‐catenin axis to promote cardiomyocyte differentiation. Conclusions and Implications PtsaN‐C@ATRA represents a novel strategy merging nanozyme catalysis with transcriptional regulation, offering potential for clinical translation in DCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesWnt Signaling PathwayTretinoinAnimalsMicebeta CateninAntioxidantsMyocytes, CardiacQuantum DotsHumans

Stichwörter der Autor:innen

Rara/Wnt/β‐catenin signalling axisall‐trans retinoic acidantioxidantcardiomyocyte differentiationdiabetic cardiomyopathysingle‐atom Pt‐N‐C nanozyme

Substanzen

Tretinoinbeta CateninAntioxidants

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

ORCID-Profile: Lina Hao, Xiufen Qu

Zitieren

APA

Hao, L., & Qu, X. (2026). Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment. British Journal of Pharmacology, 183(23), 6903-6926. https://doi.org/10.1111/bph.70633

Vancouver

Hao L, Qu X. Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment. British Journal of Pharmacology. 2026;183(23):6903-6926. doi:10.1111/bph.70633

BibTeX
@article{Hao2026,
  author = {Hao, Lina and Qu, Xiufen},
  title = {Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {23},
  pages = {6903--6926},
  doi = {10.1111/bph.70633}
}
Kostenlos starten →